To examine whether, in addition to the inhibitory effects on cell proliferation, down-regulation of PKM2 by shRNA or treatment of cells with shikonin also could affect other processes in tumor progression, we performed cell invasion assay on parental T24 cells and T24 cells deficient for PKM1 or PKM2 (Fig. 5A). The gene discussed is PKM; the disease is neoplasm.